Yes I agree they gave the CC products away for peanuts. I am assuming this deal has been on the table for a while and WP was busy chasing a better deal elsewhere but simply ran out of time . I do think another CR will happen down the track after a few successful human TAVR implants . With some good TAVR media coverage and PR work we should see AHZ SP get to the point where they can raise capital without the massive dilution they have suffered in the past
Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular, page-183
-
- There are more pages in this discussion • 107 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.30 |
Change
0.150(0.99%) |
Mkt cap ! $294.1M | |||
| Open | High | Low | Value | Volume |
| $15.35 | $15.35 | $15.00 | $92.29K | 6.09K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50 | $15.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.30 | 276 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |